King's College London

Research portal

An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine

Research output: Contribution to journalArticle

Standard

An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine. / Puledda, Francesca; Goadsby, Peter.

In: Headache, Vol. 57, No. 4, 01.04.2017, p. 685-691.

Research output: Contribution to journalArticle

Harvard

Puledda, F & Goadsby, P 2017, 'An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine', Headache, vol. 57, no. 4, pp. 685-691. https://doi.org/10.1111/head.13069

APA

Puledda, F., & Goadsby, P. (2017). An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine. Headache, 57(4), 685-691. https://doi.org/10.1111/head.13069

Vancouver

Puledda F, Goadsby P. An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine. Headache. 2017 Apr 1;57(4):685-691. https://doi.org/10.1111/head.13069

Author

Puledda, Francesca ; Goadsby, Peter. / An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine. In: Headache. 2017 ; Vol. 57, No. 4. pp. 685-691.

Bibtex Download

@article{85c21e22c9da4a098a5406bb6ec7ea5c,
title = "An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine",
abstract = "Objective: To review current neuromodulation treatments available for migraine therapy, both in the acute and preventive setting. Methods: The published literature was reviewed for studies reporting the effects of different neuromodulation strategies in migraine with and without aura. The use of non-invasive: single pulse transcranial magnetic stimulation, non-invasive vagal nerve stimulation, supraorbital nerve stimulation, and transcranial direct current stimulation, as well as invasive methods such as occipital nerve stimulation and sphenopalatine ganglion stimulation, are assessed. Results: The available evidence shows that non-invasive techniques represent promising treatment strategies, whereas an invasive approach should only be used where patients are refractory to other preventives, including non-invasive methods. Conclusions: Neuromodulation is emerging as an exciting approach to migraine therapy, especially in the context of failure of commonly used medicines or for patients who do not tolerate common side effects. More studies with appropriate blinding strategies are needed to confirm the results of these new treatment opportunities.",
keywords = "migraine, neuromodulation, occipital nerve stimulation, sphenopalatine ganglion, transcranial magnetic stimulation, vagus nerve stimulation",
author = "Francesca Puledda and Peter Goadsby",
year = "2017",
month = apr,
day = "1",
doi = "10.1111/head.13069",
language = "English",
volume = "57",
pages = "685--691",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine

AU - Puledda, Francesca

AU - Goadsby, Peter

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Objective: To review current neuromodulation treatments available for migraine therapy, both in the acute and preventive setting. Methods: The published literature was reviewed for studies reporting the effects of different neuromodulation strategies in migraine with and without aura. The use of non-invasive: single pulse transcranial magnetic stimulation, non-invasive vagal nerve stimulation, supraorbital nerve stimulation, and transcranial direct current stimulation, as well as invasive methods such as occipital nerve stimulation and sphenopalatine ganglion stimulation, are assessed. Results: The available evidence shows that non-invasive techniques represent promising treatment strategies, whereas an invasive approach should only be used where patients are refractory to other preventives, including non-invasive methods. Conclusions: Neuromodulation is emerging as an exciting approach to migraine therapy, especially in the context of failure of commonly used medicines or for patients who do not tolerate common side effects. More studies with appropriate blinding strategies are needed to confirm the results of these new treatment opportunities.

AB - Objective: To review current neuromodulation treatments available for migraine therapy, both in the acute and preventive setting. Methods: The published literature was reviewed for studies reporting the effects of different neuromodulation strategies in migraine with and without aura. The use of non-invasive: single pulse transcranial magnetic stimulation, non-invasive vagal nerve stimulation, supraorbital nerve stimulation, and transcranial direct current stimulation, as well as invasive methods such as occipital nerve stimulation and sphenopalatine ganglion stimulation, are assessed. Results: The available evidence shows that non-invasive techniques represent promising treatment strategies, whereas an invasive approach should only be used where patients are refractory to other preventives, including non-invasive methods. Conclusions: Neuromodulation is emerging as an exciting approach to migraine therapy, especially in the context of failure of commonly used medicines or for patients who do not tolerate common side effects. More studies with appropriate blinding strategies are needed to confirm the results of these new treatment opportunities.

KW - migraine

KW - neuromodulation

KW - occipital nerve stimulation

KW - sphenopalatine ganglion

KW - transcranial magnetic stimulation

KW - vagus nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=85015321144&partnerID=8YFLogxK

U2 - 10.1111/head.13069

DO - 10.1111/head.13069

M3 - Article

AN - SCOPUS:85015321144

VL - 57

SP - 685

EP - 691

JO - Headache

JF - Headache

SN - 0017-8748

IS - 4

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454